Product information

From Health Canada

Current status:

Dormant

Current status date:

2017-07-24

Original market date: See footnote 1

1996-10-17

Product name:

ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP

DIN:

01960865 Electronic product monograph is not available

Company:

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

5

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

20:12.04.92 

Anatomical Therapeutic Chemical (ATC): See footnote 4

V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS

Active ingredient group (AIG) number:See footnote5

0514462001

List of active ingredient(s)
Active ingredient(s) Strength
ADENINE 17.3 MG / 63 ML
CITRIC ACID 189 MG / 63 ML
DEXTROSE 2 G / 63 ML
SODIUM CITRATE 1.66 G / 63 ML
SODIUM PHOSPHATE MONOBASIC 140 MG / 63 ML
Version 4.0.2
Date modified: